BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+3.95%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$9.45B
AUM Growth
+$719M
(+8.2%)
Cap. Flow
+$607M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
29.09%
Holding
237
New
15
Increased
96
Reduced
78
Closed
21
Top Buys
| 1 |
ACCD
Accolade, Inc. Common Stock
ACCD
|
$53.3M |
| 2 |
ESSA Pharma
EPIX
|
$53M |
| 3 |
Revolution Medicines
RVMD
|
$47.1M |
| 4 |
SILK
Silk Road Medical, Inc. Common Stock
SILK
|
$39.8M |
| 5 |
Becton Dickinson
BDX
|
$32.4M |
Top Sells
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$100M |
| 2 |
Halozyme
HALO
|
$43.1M |
| 3 |
GNMK
GenMark Diagnostics, Inc
GNMK
|
$38.1M |
| 4 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
$33.3M |
| 5 |
Esperion Therapeutics
ESPR
|
$32.2M |
Sector Composition
| 1 | Healthcare | 95.93% |
| 2 | Industrials | 0.88% |
| 3 | Technology | 0.47% |
| 4 | Consumer Discretionary | 0.04% |
| 5 | Financials | 0.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Brown-Forman Class B
BF.B
$13.3B
| $317K | ﹤0.01% |
4,600
-1,000
| -18% | -$68.9K |
|
202
Mettler-Toledo International
MTD
$26.5B
| $312K | ﹤0.01% |
270
-150
| -36% | -$173K |
|
203
Pool Corp
POOL
$11.8B
| $311K | ﹤0.01% |
900
-300
| -25% | -$104K |
|
204
Electronic Arts
EA
$42B
| $307K | ﹤0.01% |
2,270
-1,000
| -31% | -$135K |
|
205
Verisk Analytics
VRSK
$37.7B
| $307K | ﹤0.01% |
1,739
-750
| -30% | -$132K |
|
|
ANSS
206
DELISTED
Ansys
ANSS
| $306K | ﹤0.01% |
900
-340
| -27% | -$116K |
|
207
JD.com
JD
$43.9B
| $304K | ﹤0.01% |
3,600
-1,700
| -32% | -$144K |
|
208
CoStar Group
CSGP
$37.7B
| $288K | ﹤0.01% |
3,500
-1,500
| -30% | -$123K |
|
209
IPG Photonics
IPGP
$3.48B
| $285K | ﹤0.01% |
1,350
-1,000
| -43% | -$211K |
|
|
CTLT
210
DELISTED
CATALENT, INC.
CTLT
| $284K | ﹤0.01% |
2,700
-2,000
| -43% | -$210K |
|
211
Revvity
RVTY
$9.95B
| $282K | ﹤0.01% |
2,200
-1,300
| -37% | -$167K |
|
212
CyberArk
CYBR
$23.1B
| $272K | ﹤0.01% |
2,100
-2,200
| -51% | -$285K |
|
213
StoneCo
STNE
$4.42B
| $263K | ﹤0.01% |
4,300
-3,200
| -43% | -$196K |
|
214
Mercado Libre
MELI
$123B
| $250K | ﹤0.01% |
170
-170
| -50% | -$250K |
|
|
ICPT
215
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $185K | ﹤0.01% |
8,000
| – | – |
|
216
Voyager Therapeutics
VYGR
$215M
| $150K | ﹤0.01% |
31,800
-2,680,283
| -99% | -$12.6M |
|
217
Analog Devices
ADI
$121B
| – | – |
-4,100
| Closed | -$606K |
|
218
Autoliv
ALV
$9.63B
| – | – |
-6,800
| Closed | -$626K |
|
219
Avient
AVNT
$3.41B
| – | – |
-13,600
| Closed | -$548K |
|
220
Blackbaud
BLKB
$3.22B
| – | – |
-4,107
| Closed | -$236K |
|
221
Broadridge
BR
$29.5B
| – | – |
-3,400
| Closed | -$521K |
|
222
Cidara Therapeutics
CDTX
$1.65B
| – | – |
-141,125
| Closed | -$5.65M |
|
223
Coherus Oncology, Inc. Common Stock
CHRS
$152M
| – | – |
-149,000
| Closed | -$2.59M |
|
224
Quest Diagnostics
DGX
$20.1B
| – | – |
-6,749
| Closed | -$804K |
|
225
Galapagos
GLPG
$2.1B
| – | – |
-9,500
| Closed | -$940K |
|